J D Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.29 M
as on 23-10-2024
- Company Age 34 Year, 26 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.24 Cr
as on 23-10-2024
- Satisfied Charges ₹ 5.07 Cr
as on 23-10-2024
- Revenue -10.10%
(FY 2023)
- Profit -17.95%
(FY 2023)
- Ebitda -9.73%
(FY 2023)
- Net Worth -5.70%
(FY 2023)
- Total Assets 14.25%
(FY 2023)
About J D Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.29 M.
The company currently has active open charges totaling ₹26.24 Cr. The company has closed loans amounting to ₹5.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
Geetha Yezhuvath, Rohith Das, Roopa Mahesh, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195KL1990PTC005906
- Company No.
005906
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 1990
- Date of AGM
24 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at J D Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohith Das  | Managing Director | 01-Sep-2014 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Geetha Yezhuvath | Whole-Time Director | 02-Sep-1991 | Current |
| Roopa Mahesh | Director | Current | |
| Suraja Vidyaprasad | Director | Current |
Financial Performance of J D Diagnostics.
J D Diagnostics Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.1% decrease. The company also saw a substantial fall in profitability, with a 17.95% decrease in profit. The company's net worth dipped by a decrease of 5.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J D Diagnostics?
In 2023, J D Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jun 2024 | ₹5.00 Cr | Open |
Axis Bank Limited Creation Date: 31 Dec 2020 | ₹5.65 M | Open |
Axis Bank Limited Creation Date: 17 Jul 2020 | ₹6.10 M | Open |
How Many Employees Work at J D Diagnostics?
Unlock and access historical data on people associated with J D Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J D Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J D Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
